Navigating EPA’s Temporary Allowances and Expedited Review Pathways for Disinfectants Used against SARS-CoV-2 (COVID-19)
During the pandemic, EPA and the antimicrobial industry have had to adapt to ensure that disinfectants are available for use against SARS-CoV-2. In response to supply chain challenges and overwhelming demand, EPA has developed new procedures, guidance and has provided temporary amendments to PR Notice 98-10 to meet this goal and provide the industry with expedited approval pathways for eligible disinfectants. Join this webinar to hear HCPA and EPA’s insight regarding these documents and guidance on how to follow the EPA’s procedures for expedited submissions. EPA will be on the webinar to answer questions.
Tony Herber, Principal Regulatory Consultant (Science & Regulatory Consultants)
John Reilly, Manager of Regulatory Affairs (Sterilex)